Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE OF COMMON STOCK (Details Narrative)

v3.23.2
NET LOSS PER SHARE OF COMMON STOCK (Details Narrative) - shares
9 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 11,473,236 11,094,104
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 300,000 300,000